ANCA-positive vasculitis associated with simvastatin/ezetimibe: expanding the spectrum of statin-induced autoimmunity?

Int J Rheum Dis. 2010 Aug;13(3):e29-31. doi: 10.1111/j.1756-185X.2010.01481.x.

Abstract

Although autoimmune syndromes such as systemic lupus erythematosus and dermatomyositis have been previously reported in association with statin use, vasculitis has not been well described. We present a patient with an antineutrophil cytoplasmic antibody-positive, predominantly cutaneous vasculitis, the temporal course of which was associated with simvastatin/ezetimibe use. The patient's serologic findings were consistent with drug-induced disease, with high titer antimyeloperoxidase, in addition to antinuclear and anti-Ro (SSA) antibodies. The patient demonstrated complete resolution of symptoms simply by withdrawing the drug.

Publication types

  • Case Reports

MeSH terms

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / chemically induced*
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / immunology
  • Antibodies, Antineutrophil Cytoplasmic / blood
  • Anticholesteremic Agents / adverse effects*
  • Autoimmunity / drug effects*
  • Azetidines / adverse effects*
  • Biomarkers / blood
  • Drug Combinations
  • Ezetimibe, Simvastatin Drug Combination
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Male
  • Middle Aged
  • Peroxidase / immunology
  • Ribonucleoproteins / immunology
  • Simvastatin / adverse effects*

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Anticholesteremic Agents
  • Azetidines
  • Biomarkers
  • Drug Combinations
  • Ezetimibe, Simvastatin Drug Combination
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Ribonucleoproteins
  • SS-A antigen
  • Simvastatin
  • Peroxidase